Alabdullah et al., 2020 - Google Patents
Evaluation of the efficacy of a cholera toxin-based staphylococcus aureus vaccine against bovine intramammary challengeAlabdullah et al., 2020
View HTML- Document ID
- 1051106201570180371
- Author
- Alabdullah H
- Overgaard E
- Scarbrough D
- Williams J
- Mohammad Mousa O
- Dunn G
- Bond L
- McGuire M
- Tinker J
- Publication year
- Publication venue
- Vaccines
External Links
Snippet
Staphylococcus aureus (S. aureus) is a primary agent of bovine mastitis and a source of significant economic loss for the dairy industry. We previously reported antigen-specific immune induction in the milk and serum of dairy cows following vaccination with a cholera …
- 229960005486 vaccines 0 title abstract description 89
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rzewuska et al. | Pathogenicity and virulence of Trueperella pyogenes: a review | |
| Cadenas-Fernández et al. | Adenovirus-vectored African swine fever virus antigens cocktail is not protective against virulent Arm07 isolate in Eurasian wild boar | |
| Abdurrahman et al. | Allergy—a new role for T cell superantigens of Staphylococcus aureus? | |
| Fang et al. | Staphylococcal enterotoxin C is an important virulence factor for mastitis | |
| Ivanov et al. | Inflammasomes as targets for adjuvants | |
| Xu et al. | Superantigens modulate bacterial density during Staphylococcus aureus nasal colonization | |
| Morais et al. | Next-generation whole-cell pneumococcal vaccine | |
| Rainard et al. | Progress towards the elusive mastitis vaccines | |
| Alabdullah et al. | Evaluation of the efficacy of a cholera toxin-based staphylococcus aureus vaccine against bovine intramammary challenge | |
| Cheng et al. | The ADP-ribosylating toxins of Salmonella | |
| Dudek et al. | Vaccines for mycoplasma diseases of small ruminants: A neglected area of research | |
| Techawiwattanaboon et al. | A comparison of intramuscular and subcutaneous administration of LigA subunit vaccine adjuvanted with neutral liposomal formulation containing monophosphoryl lipid A and QS21 | |
| Byvalov et al. | Yersinia outer membrane vesicles as potential vaccine candidates in protecting against plague | |
| Gupta et al. | Simultaneous immunization with Omp25 and L7/L12 provides protection against brucellosis in mice | |
| Rukkawattanakul et al. | Human scFvs that counteract bioactivities of Staphylococcus aureus TSST-1 | |
| Techawiwattanaboon et al. | Reduced renal colonization and enhanced protection by leptospiral factor H binding proteins as a multisubunit vaccine against leptospirosis in hamsters | |
| Jiang et al. | Protective immunity against canine distemper virus in dogs induced by intranasal immunization with a recombinant probiotic expressing the viral H protein | |
| Harrell et al. | An outer membrane vesicle-adjuvanted oral vaccine protects against lethal, oral salmonella infection | |
| Bai et al. | Protection efficacy of oral bait probiotic vaccine constitutively expressing tetravalent toxoids against Clostridium perfringens exotoxins in livestock (rabbits) | |
| Li et al. | A Streptococcus suis live vaccine suppresses streptococcal toxic shock-like syndrome and provides sequence type-independent protection | |
| Nandre et al. | Generation of a safe Salmonella Gallinarum vaccine candidate that secretes an adjuvant protein with immunogenicity and protective efficacy against fowl typhoid | |
| Xue et al. | Mycoplasma suis alpha-enolase subunit vaccine induces an immune response in experimental animals | |
| Llanos Salinas et al. | GspD, the type II secretion system secretin of Leptospira, protects hamsters against lethal infection with a virulent L. interrogans isolate | |
| Prapong et al. | Leptospira borgpetersenii leucine-rich repeat proteins provide strong protective efficacy as novel leptospiral vaccine candidates | |
| Pan et al. | Oral delivery of novel recombinant lactobacillus elicit high protection against staphylococcus aureus pulmonary and skin infections |